Fidelis Capital Partners’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $426K | Sell |
1,541
-150
| -9% | -$41.4K | 0.04% | 297 |
|
|
2025
Q1 | $713K | Buy |
1,691
+65
| +4% | +$27.4K | 0.08% | 197 |
|
|
2024
Q4 | $659K | Sell |
1,626
-2,425
| -60% | -$982K | 0.07% | 216 |
|
|
2024
Q3 | $1.68M | Buy |
4,051
+499
| +14% | +$207K | 0.2% | 88 |
|
|
2024
Q2 | $1.85M | Buy |
3,552
+1,168
| +49% | +$609K | 0.26% | 72 |
|
|
2024
Q1 | $1.24M | Buy |
2,384
+840
| +54% | +$436K | 0.19% | 96 |
|
|
2023
Q4 | $728K | Buy |
1,544
+232
| +18% | +$109K | 0.16% | 127 |
|
|
2023
Q3 | $573K | Sell |
1,312
-66
| -5% | -$28.8K | 0.2% | 117 |
|
|
2023
Q2 | $612K | Buy |
1,378
+111
| +9% | +$49.3K | 0.22% | 109 |
|
|
2023
Q1 | $588K | Buy |
+1,267
| New | +$588K | 0.25% | 99 |
|